142 related articles for article (PubMed ID: 32778976)
21. Erlotinib complexation with randomly methylated
Erdoğar N; Akkın S; Varan G; Bilensoy E
Pharm Dev Technol; 2021 Sep; 26(7):797-806. PubMed ID: 34219578
[TBL] [Abstract][Full Text] [Related]
22. Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab.
Pang J; Xing H; Sun Y; Feng S; Wang S
Biomed Pharmacother; 2020 May; 125():109861. PubMed ID: 32070872
[TBL] [Abstract][Full Text] [Related]
23. Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.
Saravanakumar K; Sathiyaseelan A; Mariadoss AVA; Jeevithan E; Hu X; Shin S; Wang MH
Carbohydr Polym; 2020 Oct; 245():116407. PubMed ID: 32718591
[TBL] [Abstract][Full Text] [Related]
24. Poly(ester-thioether) microspheres co-loaded with erlotinib and α-tocopheryl succinate for combinational therapy of non-small cell lung cancer.
Cheng F; Peng X; Meng G; Pu Y; Luo K; He B
J Mater Chem B; 2020 Feb; 8(8):1728-1738. PubMed ID: 32022097
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of
Zhong T; Liu X; Li H; Zhang J
Drug Deliv; 2021 Dec; 28(1):2108-2118. PubMed ID: 34607478
[TBL] [Abstract][Full Text] [Related]
26. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
27. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
28. Development, optimization and in vitro evaluation of oxaliplatin loaded nanoparticles in non-small cell lung cancer.
Esim O; Bakirhan NK; Yildirim N; Sarper M; Savaser A; Ozkan SA; Ozkan Y
Daru; 2020 Dec; 28(2):673-684. PubMed ID: 33089432
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and self-assembly of amphiphilic poly(acrylicacid)-poly(ɛ-caprolactone)-poly(acrylicacid) block copolymer as novel carrier for 7-ethyl-10-hydroxy camptothecin.
Djurdjic B; Dimchevska S; Geskovski N; Petrusevska M; Gancheva V; Georgiev G; Petrov P; Goracinova K
J Biomater Appl; 2015 Jan; 29(6):867-81. PubMed ID: 25209880
[TBL] [Abstract][Full Text] [Related]
30. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
31. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
32. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
33. Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer.
Yu X; Wu H; Hu H; Dong Z; Dang Y; Qi Q; Wang Y; Du S; Lu Y
Drug Deliv; 2020 Dec; 27(1):100-109. PubMed ID: 31870183
[No Abstract] [Full Text] [Related]
34. pH responsive delivery of lumefantrine with calcium phosphate nanoparticles loaded lipidic cubosomes for the site specific treatment of lung cancer.
Sethuraman V; Janakiraman K; Krishnaswami V; Natesan S; Kandasamy R
Chem Phys Lipids; 2019 Nov; 224():104763. PubMed ID: 30951710
[TBL] [Abstract][Full Text] [Related]
35. Assessing the selective therapeutic efficacy of superparamagnetic erlotinib nanoparticles in lung cancer by using quantitative magnetic resonance imaging and a nuclear factor kappa-B reporter gene system.
Hsu FT; Liu HS; Ali AAA; Tsai PH; Kao YC; Lu CF; Huang HS; Chen CY
Nanomedicine; 2018 Apr; 14(3):1019-1031. PubMed ID: 29391212
[TBL] [Abstract][Full Text] [Related]
36. Co-Loaded Curcumin and Methotrexate Nanocapsules Enhance Cytotoxicity against Non-Small-Cell Lung Cancer Cells.
Rudnik LAC; Farago PV; Manfron Budel J; Lyra A; Barboza FM; Klein T; Kanunfre CC; Nadal JM; Bandéca MC; Raman V; Novatski A; Loguércio AD; Zanin SMW
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326159
[No Abstract] [Full Text] [Related]
37. Synthesis and biological assay of erlotinib analogues and BSA-conjugated erlotinib analogue.
Boobalan R; Liu KK; Chao JI; Chen C
Bioorg Med Chem Lett; 2017 Apr; 27(8):1784-1788. PubMed ID: 28268137
[TBL] [Abstract][Full Text] [Related]
38. Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Asadollahi L; Mahoutforoush A; Dorreyatim SS; Soltanfam T; Paiva-Santos AC; Peixoto D; Veiga F; Hamishehkar H; Zeinali M; Abbaspour-Ravasjani S
Int J Pharm; 2022 Aug; 624():122027. PubMed ID: 35850183
[TBL] [Abstract][Full Text] [Related]
39. miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells.
Zhang W; Lin J; Wang P; Sun J
J Drug Target; 2017 Feb; 25(2):125-131. PubMed ID: 27633093
[TBL] [Abstract][Full Text] [Related]
40. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
